Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Avatar

Follicular Lymphoma: Frontline Therapy, Bendamustin plus Rituximab or Bendamustine plus Obinutuzumab, Maintenance and Salvage Therapy

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Mathias J. Rummel
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Mathias J. Rummel
125 views
October 18, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Related Content

AUTOPLAY
06:33
Christopher Flowers

FDA Approval of Zanubrutinib in R/R FL: What You Need to Know

08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou
13:56
SOHO 2023 Eleventh Annual Meeting

Follicular Lymphoma Management: What Is the New Order?

Feat. B. Kahl
27:51
Louisville Hematology Highlights

Summary of Recent Advances in Follicular Lymphoma

Feat. S. Gaballa
19:46
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Management of Indolent NHL

Feat. E. Brem
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
08:58
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Zanubrutinib + Obinutuzumab vs. Obinutuzu…

Feat. C. Flowers
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
37:44
University of Colorado Division of Hematology

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

Feat. M. Kamdar
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
26:58
Total Health

Update on Cellular Therapy in Lymphoma

Feat. B. Randolph
10:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Epcoritamab + R² Regimen and Responses in…

Feat. R. Merryman
10:49
Monia Marchetti

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

42:09
University of Colorado Department of Medicine

Immunotherapy in Lymphomas: The Present and the Future

Feat. M. Kamdar
04:16
GRACE

Mosunetuzumab for R/R Follicular Lymphoma

Feat. T. Phillips
27:49
MyCancerHaven

Overview of the Diagnosis and Treatment of Follicular Lymphoma

Feat. R. Vij, T. Fehniger
03:33
PrecisCa

Mosunetuzumab in R/R Follicular Lymphoma

Feat. M. Kamdar
21:19
MyCancerHaven

Experts Discuss the Use of Bispecific Antibodies in NHL

Feat. R. Vij, B. Kahl